Used in pharmaceutical research as a key intermediate in the synthesis of targeted cancer therapies, particularly in the development of selective kinase inhibitors. Its structure enables effective binding to specific enzyme targets involved in tumor growth and signal transduction pathways. Due to its stereochemical configuration, it enhances selectivity and potency in drug candidates, improving pharmacokinetic properties such as metabolic stability and oral bioavailability. It is also employed in structure-activity relationship (SAR) studies to optimize drug efficacy and reduce off-target effects.